Skip to Content

Ironwood Pharmaceuticals Inc Class A IRWD

Morningstar Rating
$9.07 −0.37 (3.87%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

IRWD is trading at a 37% discount.
Price
$9.03
Fair Value
$59.76
Uncertainty
Extreme
1-Star Price
$81.67
5-Star Price
$8.31
Economic Moat
Kdch
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if IRWD is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$9.43
Day Range
$8.759.39
52-Week Range
$8.0815.70
Bid/Ask
$9.11 / $9.15
Market Cap
$1.42 Bil
Volume/Avg
15.9 Mil / 3.7 Mil

Key Statistics

Price/Earnings (Normalized)
8.03
Price/Sales
3.18
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Ironwood Pharmaceuticals is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing innovative product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Core
Total Number of Employees
267

Comparables

Valuation

Metric
IRWD
INVA
AMLX
Price/Earnings (Normalized)
8.039.2815.83
Price/Book Value
1.452.92
Price/Sales
3.184.263.44
Price/Cash Flow
8.187.9816.88
Price/Earnings
IRWD
INVA
AMLX

Financial Strength

Metric
IRWD
INVA
AMLX
Quick Ratio
0.807.285.01
Current Ratio
0.849.035.66
Interest Coverage
−43.7110.31
Quick Ratio
IRWD
INVA
AMLX

Profitability

Metric
IRWD
INVA
AMLX
Return on Assets (Normalized)
−126.33%14.79%18.55%
Return on Equity (Normalized)
−1,415.33%29.29%21.48%
Return on Invested Capital (Normalized)
−141.06%16.71%17.45%
Return on Assets
IRWD
INVA
AMLX
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
ZTS
Zoetis Inc Class ADpl$87.4 Bil
MKKGY
Merck KGaA ADRCtrpq$74.3 Bil
HLN
Haleon PLC ADRXrcw$38.5 Bil
VTRS
Viatris IncXcfc$15.1 Bil
RDY
Dr Reddy's Laboratories Ltd ADRSsthz$12.4 Bil
CTLT
Catalent IncHqvtyml$10.3 Bil
CURLF
Curaleaf Holdings IncXng$3.6 Bil
PRGO
Perrigo Co PLCRjmhm$3.6 Bil
PBH
Prestige Consumer Healthcare IncNyvbdrz$3.5 Bil
GTBIF
Green Thumb Industries IncLdxj$3.1 Bil

Sponsor Center